Skip to main content
. Author manuscript; available in PMC: 2014 Apr 30.
Published in final edited form as: Spine (Phila Pa 1976). 2011 Feb 15;36(4):290–307. doi: 10.1097/BRS.0b013e3181ef9d8c

TABLE 3. Subgroup Results from Adjusted* As-Treated Outcome Analysis by Diabetes for the Randomized and Observational Cohorts Combined Patients with Lumbar Intervertebral Disk Herniation.

Outcome 1-Yr 2-Yr 3-Yr 4-Yr
IDH (RCT & OBS) Diabetes Surgical Nonoperative Treatment Effect,
OR (95% CI)
Surgical Nonoperative Treatment Effect,
OR (95% CI)
Surgical Nonoperative Treatment Effect,
OR (95% CI)
Surgical Nonoperative Treatment Effect,
OR (95% CI)
Primary outcomes
 SF-36 bodily pain (0–100),
 mean (SE)
Not diabetic 45.9 (0.9) 33.1 (1.2) 12.7 (9.9 to 15.5) 45.2 (0.9) 35.1 (1.2) 10.1 (7.2 to 13) 45.9 (1) 35 (1.3) 10.9 (7.8 to 13.9) 47.2 (1) 33.9 (1.4) 13.3 (10.2 to 16.5)
Diabetic 41.4 (5.1) 34.5 (5.9) 6.8 (−7.7 to 21.3) 34.3 (5.1) 34.2 (6.2) 0.1 (−14.6 to 14.8) 33 (5.9) 25.9 (6.4) 7.1 (−9.2 to 23.4) 46.8 (5.6) 37.7 (6.9) 9.1 (−7.6 to 25.7
P § 0.39 0.82 0.43 0.035 0.89 0.19 0.031 0.16 0.66 0.95 0.58 0.62
 SF-36 physical function
 (0–100), mean (SE)
Not diabetic 44 (0.8) 28.5 (1.1) 15.5 (13 to 18.1) 43.5 (0.8) 30.5 (1.1) 13 (10.4 to 15.6) 43.5 (0.9) 30.8 (1.2) 12.8 (10.1 to 15.5) 44.4 (0.9) 30.3 (1.2) 14.1 (11.3 to 17)
Diabetic 31 (4.7) 29.7 (5.4) 1.2 (−11.9 to 14.4) 26.6 (4.7) 29.2 (5.6) −2.7 (−16 to 10.7) 35.2 (5.4) 27.1 (5.9) 8.1 (−6.6 to 22.8) 28.3 (5.2) 20.8 (6.2) 7.4 (−7.6 to 22.5)
P 0.007 0.83 0.036 <0.001 0.83 0.024 0.13 0.54 0.54 0.002 0.13 0.39
Mental component summary
(0–100), mean SE)
Not diabetic 7.6 (0.4) 4.4 (0.5) 3.2 (2.1 to 4.3) 6.4 (0.4) 4.4 (0.5) 1.9 (0.8 to 3.1) 6.3 (0.4) 4.1 (0.5) 2.2 (1 to 3.4) 6 (0.4) 4.5 (0.5) 1.5 (0.2 to 2.8)
Diabetic 6.8 (2.1) 2 (2.4) 4.8 (−1 to 10.6) 6.1 (2.1) 6.4 (2.5) −0.3 (−6.2 to 5.7) 3.9 (2.4) 5.1 (2.6) −1.3 (−7.8 to 5.3) 6.2 (2.3) 2.2 (2.9) 4 (−3 to 10.9)
P 0.70 0.32 0.60 0.89 0.45 0.47 0.31 0.70 0.31 0.94 0.42 0.49
Oswestry Disability Index
(0–100), mean (SE)
Not diabetic −37 (0.7) −23 (0.9) −14 (−16.1 to −11.9) −36.7 (0.7) −24.8 (0.9) −11.9 (−14 to −9.7) −36.8 (0.7) −25.3 (1) −11.5 (−13.8 to −9.3) −37.4 (0.8) −25.1 (1) −12.3 (−14.7 to −10)
Diabetic −32.3 (4) −29 (4.5) −3.3 (−14 to 7.5) −27 (3.9) −29.1 (4.7) 2.1 (−8.8 to 13) −32.8 (4.5) −22.1 (4.9) −10.6 (−22.6 to 1.3) −34.3 (4.3) −29.9 (5.1) −4.4 (−16.6 to 7.8)
P 0.25 0.19 0.054 0.015 0.37 0.013 0.37 0.52 0.89 0.48 0.36 0.21
Very/somewhat satisfied with
symptoms (%)
Not diabetic 71.5 46.3 25.3 (19.2 to 31.3) 72.4 52.7 19.7 (13.5 to 25.8) 71.6 52.8 18.8 (12.3 to 25.4) 73.5 50 23.4 (16.6 to 30.3)
Diabetic 70.2 59.8 10.4 (−19.7 to 40.5) 65.8 30.8 35 (5,65) 64.1 50.7 13.4 (−22.5 to 49.3) 85.1 61.6 23.5 (−8.5 to 55.5)
P 0.89 0.28 0.37 0.53 0.18 0.48 0.57 0.89 0.76 0.32 0.41 0.79
Very/somewhat satisfied with
care (%)
Not diabetic 92.4 83.7 8.8 (4.4 to 13.1) 90.7 80.1 10.6 (5.8 to 15.4) 88.6 75.1 13.5 (8 to 19) 90.5 77.9 12.6 (7 to 18.3)
Diabetic 80.5 76 4.5 (−21.5 to 30.5) 85.3 66 19.3 (−8.8 to 47.4) 93.7 81.6 12.1 (−11.9 to 36.1) 80.4 82.8 −2.3 (−30.6 to 26)
P 0.048 0.33 0.39 0.39 0.20 0.80 0.50 0.58 0.82 0.22 0.71 0.29
Self-rated progress, major
improvement (%)
Not diabetic 80.2 56.3 23.9 (18.1 to 29.8) 75.7 60.8 14.8 (8.8 to 20.9) 73.5 57 16.4 (9.9 to 22.9) 76.6 54.5 22 (15.2 to 28.8)
Diabetic 77.4 70.4 7 (−20.6 to 34.6) 63.2 65.8 −2.6 (−33.5 to 28.3) 62.7 64.3 −1.6 (−36.2 to 33.1) 67.6 65.8 1.9 (−32.9 to 36.6)
P 0.76 0.26 0.30 0.21 0.72 0.29 0.36 0.60 0.31 0.45 0.44 0.29
Work status, working (%) Not diabetic 79.3 77.4 1.9 (−2.9 to 6.6) 78.7 78.9 −0.2 (−5 to 4.5) 76.4 74.4 2.1 (−3.3 to 7.4) 77.5 73.2 4.3 (−1.4 to 9.9)
Diabetic 62.1 69.2 −7.1 (−34.6 to 20.3) 57.4 54.3 3 (−27.3 to 33.4) 72.3 63.8 8.5 (−21.4 to 38.4) 57.8 70.2 −12.5 (−44.2 to 19.3)
P 0.044 0.30 0.38 0.016 0.015 0.81 0.64 0.30 0.64 0.019 0.72 0.094
*

Adjusted for age, sex, body mass index, baseline score (for SF-36, ODI), and center.

Treatment effect is the difference between the surgical and nonoperative mean change from baseline. Analysis is done by using a mixed model with a random subject intercept term. Treatment is a time-varying covariate where a patients’ experience before surgery is attributed to the nonoperative arm, and time is measured from enrollment; his/her postsurgery outcomes are attributed to the surgical arm, and time is measured from the time of surgery.

Patients who report being told by their doctors that they have diabetes and also report that they are currently receiving treatment for diabetes.

§

P values at each time-point are from multiple degree-of-freedom Wald tests.